Skip to main content
. 2023 Jul 17;11(7):1828. doi: 10.3390/microorganisms11071828

Table 3.

Results of logistic regressions showing association of outcome (death, recovery, chronicity/recurrence) with variables of interest.

Outcome: Death (n = 53)
Variable OR 95%CI p Value
Surgical treatment 0.687 [0.376–1.290] 0.23
Treatment duration, months 0.54 [0.411–0.675] <0.001
Time to diagnosis
0–1 month
1–6 months
>6 months

0.712
1.541
0.930

[0.382–1.287]
[0.863 2.759]
[0.391 1.966]

0.27
0.143
0.859
Immunocompromised 1.507 [0.837–2.798] 0.18
Site of infection
Basicranium
Extremities (except foot)
Foot
Other cranium bones
Pelvis and hip
Ribs and sternum
Shoulder
Splanchnocranium
Vertebrae

1.282
0.598
-
1.968
0.412
1.127
0.493
0.794
1.762

[0.423–3.185]
[0.293–1.140]
-
[0.884–4.054]
[0.066–1.405]
[0.472–2.396]
[0.027–2.492]
[0.294–1.808]
[0.957–3.176]

0.622
0.135
-
0.078
0.232
0.768
0.497
0.613
0.063
Aetiological agents
Aspergillus
Blastomyces
Candida
Coccidioides
Cryptococcus
Fusarium
Histoplasma
Mucormycosis
Paracoccidioides
Phaeohyphomycosis
Scedosporium
Other

2.69
-
0.682
0.390
0.597
3.135
0.611
1.231
-
-
0.792
1.269

[1.498–4.829]
-
[0.289–1.427]
[0.021–1.934]
[0.222–1.348]
[0.670–11.236]
[0.033–3.163]
[0.450–2.865]
-
-
[0.185–2.329]
[0.291–3.893]

<0.001
-
0.343
0.364
0.254
0.099
0.638
0.653
-
-
0.709
0.709
Outcome: Recovery (n = 399)
Variable OR 95%CI p Value
Surgical treatment 1.541 [0.913–2.561] 0.98
Treatment duration, months 1.144 [1.060–1.252] 0.001
Time to diagnosis
0–1 month
1–6 months
>6 months

1.075
1.098
0.704

[0.659–1.771]
[0.673–1.808]
[0.387–1.335]

0.772
0.619
0.693
Immunocompromised 0.835 [0.507–1.358] 0.472
Site of infection
Basicranium
Extremities (except foot)
Foot
Other cranium bones
Pelvis and hip
Ribs and sternum
Shoulder
Splanchnocranium
Vertebrae

0.847
1.373
7.358
0.684
1.112
0.706
0.933
1.143
0.514

[0.377–2.165]
[0.811–2.402]
[1.551–131.77]
[0.352–1.418]
[0.481–3.031]
[0.378–1.391]
[0.296–4.118]
[0.578–2.476]
[0.312–0.857]

0.707
0.25
0.051
0.282
0.818
0.292
0.915
0.716
0.009
Aetiological agents
Aspergillus
Blastomyces
Candida
Coccidioides
Cryptococcus
Fusarium
Histoplasma
Mucormycosis
Paracoccidioides
Phaeohyphomycosis
Scedosporium
Other

0.646
3.732
1.003
0.845
1.737
0.458
2.66
0.975
-
-
0.895
0.513

[0.389–1.087]
[0.754–67.632]
[0.561–1.879]
[0.303–3]
[0.869–3.873]
[0.124–2.162]
[0.518–48.68]
[0.458–2.326]
-
-
[0.379–2.465]
[0.203–1.471]

0.094
0.203
0.992
0.768
0.143
0.266
0.349
0.951
-
-
0.813
0.179
Outcome: Recurrence/Chronicity (n = 62)
Variable OR 95%CI p Value
Surgical treatment 1.266 [0.696–2.422] 0.455
Treatment duration, months 1.088 [1.039–1.142] <0.001
Time to diagnosis
0–1 month
1–6 months
>6 months

0.896
0.478
3.048

[0.512–1.545]
[0.257–0.850]
[1.643–5.534]

0.698
0.014
<0.001
Immunocompromised 0.661 [0.385–1.129] 0.129
Site of infection
Basicranium
Extremities (except foot)
Foot
Other cranium bones
Pelvis and hip
Ribs and sternum
Shoulder
Splanchnocranium
Vertebrae

0.363
1.024
0.827
0.975
2.184
1.643
2.953
1.091
1.461

[0.057–1.233]
[0.568–1.793]
[0.240–2.182]
[0.387–2.138]
[0.933–4.692]
[0.791–3.199]
[0.912–8.286]
[0.481–2.239]
[0.814–2.557]

0.171
0.934
0.73
0.954
0.055
0.16
0.049
0.821
0.192
Aetiological agents
Aspergillus
Blastomyces
Candida
Coccidioides
Cryptococcus
Fusarium
Histoplasma
Mucormycosis
Paracoccidioides
Phaeohyphomycosis
Scedosporium
Other

1.001
0.782
1.206
1.618
0.487
0.665
3.966
0.802
-
1.688
1.215
1.069

[0.537–1.789]
[0.122–2.821]
[0.614–2.242]
[0.453–4.555]
[0.182–1.089]
[0.035–3.566]
[1.184–11.907]
[0.268–1.943]
-
[0.085–11.647]
[0.4–3.029]
[0.245–3.263]

0.998
0.747
0.567
0.401
0.108
0.7
0.016
0.656
-
0.642
0.7
0.916